CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Executive or director change
- 4 Planned sale Chief Scientific Officer sold 492,400 shares at an average $21.89 ($10,780,409)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Officer, MRD sold 5,000 shares at $23.00 ($115,000)
- 4 Planned sale Chief People Officer sold 105,762 shares at $22.59 ($2,389,164)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Scientific Officer sold 386,240 shares at an average $22.01 ($8,501,149)
- 4 Planned sale Chief People Officer sold 95,842 shares at an average $22.51 ($2,157,683)
- 4 Planned sale Chief Commercial Officer, MRD sold 487 shares at $22.00 ($10,714)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Ofc Imm Med sold 165,802 shares at an average $21.13 ($3,503,510)
- 4 Planned sale Chief Commercial Officer, MRD sold 5,000 shares at $20.50 ($102,500)
- 4 Planned sale Director sold 52,084 shares at $20.18 ($1,051,055)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 3 of 42 · 836 filings